CSIMarket


Celcuity Inc   (CELC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


 

Celcuity Inc

CELC's Financial Statements and Analysis



Celcuity Inc narrowed first quarter of 2024 net loss per share of $-0.64 compare to net loss per share of $-0.68 recorded in the same quarter a year ago a decrease compare to $-0.61 realized in previous quarter.


first quarter of 2024
Earnings Per Share Revenues
$ -0.64 $  0 Mill
$+0.04     Unch.    



Celcuity Inc 's Revenue fell by 0 % in first quarter of 2024 (Mar 31 2024) year on year, to $0 million and declined by sequentially.


Celcuity Inc is

More on CELC's Income Statement



Celcuity Inc in the first quarter of 2024 recorded net loss of $-21.612 million, an increase from net loss of $-11.581 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-26.359 million realized in previous quarter.

More on CELC's Growth

Celcuity Inc Inventories
CELC's Cash flow In the first quarter of 2024 company's net cash flow was $1 million, capital expenditures grew by -0.112044-19.96%, to $0 millions compare to same quarter a year ago

More on CELC's Cash flow Statement


Celcuity Inc does not pay out common stock dividend.

In trailing twelve-month period Celcuity Inc payed $ -2.11 cash per share, on a free-cash flow basis .

Book value fell by -32.51 % sequentially to $3.98 per share, -77.87% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.98 per share from $ 5.89.

Company issued 9.90 million shares or 41.76 % in Mar 31 2024.


More on CELC's Dividends

 Market Capitalization (Millions) 505
 Shares Outstanding (Millions) 34
 Total Debt (Millions $) 38
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -75
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Celcuity Inc does not pay out common stock dividend.

In trailing twelve-month period Celcuity Inc had negative $ -2.11 cash flow per share, on a free-cash flow basis .

Book value fell by -32.51 % sequentially to $3.98 per share, -77.87% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.98 per share from $ 5.89.

Company issued 9.90 million shares or 41.76 % in Mar 31 2024.


More on CELC's Balance Sheets

 Market Capitalization (Millions) 505
 Shares Outstanding (Millions) 34
 Total Debt (Millions $) 38
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -75
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Celcuity Inc Earnings

Expenses Skyrocket in Q2 2023 as Celcuity Inc Faces Uphill Battle, but Investors Stay Hopeful for Bright Future

During the past five days, Celcuity Inc's stock has experienced a slight increase of 0.81%. While this may appear positive at first glance, it is important to note that the year-to-date performance of the stock is still quite negative, standing at -22.39%. Additionally, the stock is currently trading 32.7% above its 52-week low.
Celcuity Inc, a company in the Medical Laboratories sector, recently reported its earnings for the second quarter of 2023. The company announced an operating loss of $-15.055485 million during this period. While this news may seem discouraging, investors remain optimistic about the future prospects of the company. They anticipate the development of a new business model in the nea...

Celcuity Inc's Existing Expenditures Surge in 1Q 2023, Prompting Cautious Investor Approach in Healthcare Sector

Investors may want to exercise caution when considering Celcuity Inc as a potential investment opportunity in the Healthcare sector. The company recorded a cumulative net loss of $-44 million during the 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -39.03%. Compared to other companies in the same sector, Celcuity's ROI ranks at 4199, with 568 other companies having a higher ROI.
During the January to March 31 reporting cycle, the company's operating loss was recorded at $-12.547537 million, a significant decline from the first quarter of 2022, when it was recorded at $-7.50...